{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:52:39Z","timestamp":1786989159111,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.fertnstert.2024.11.021","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:33:48Z","timestamp":1732588428000},"page":"827-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antim\u00fcllerian hormone and antral follicle count thresholds for hyperresponse risk assessment in in\u00a0vitro fertilization: a Hyperresponse Risk Assessment consensus study"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-409X","authenticated-orcid":false,"given":"Alyssa","family":"Hochberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro C.","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Yarali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan N.","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.11.021_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/humrep\/dev149","article-title":"Sub-optimal responders following controlled ovarian stimulation: an overlooked group?","volume":"30","author":"Polyzos","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib3","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI\u2020","volume":"2020","author":"Ovarian Stimulation","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in\u00a0vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","article-title":"Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-M\u00fcllerian hormone versus small antral follicle count (2-6 mm)","volume":"26","author":"Aflatoonian","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0015-0282(01)02018-0","article-title":"Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo","volume":"76","author":"Valbuena","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.fertnstert.2006.02.086","article-title":"Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in\u00a0vitro fertilization-embryo transfer","volume":"86","author":"Mitwally","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.fertnstert.2009.02.066","article-title":"Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in\u00a0vitro fertilization in a concentration-dependent manner","volume":"93","author":"Joo","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in\u00a0vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10815-023-02757-4","article-title":"The HERA (hyper-response risk assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization","volume":"40","author":"Feferkorn","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib14","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s10815-015-0600-5","article-title":"Effect of follicle-stimulating hormone receptor Asn680Ser polymorphism on the outcomes of controlled ovarian hyperstimulation: an updated meta-analysis of 16 cohort studies","volume":"32","author":"Tang","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/humrep\/deab068","article-title":"The effect of polymorphisms in FSHR and FSHB genes on ovarian response: a prospective multicenter multinational study in Europe and Asia","volume":"36","author":"Polyzos","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/FPC.0000000000000374","article-title":"The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation","volume":"29","author":"Nenonen","year":"2019","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2010.07.1069","article-title":"Age-specific nomogram for the decline in antral follicle count throughout the reproductive period","volume":"95","author":"La Marca","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib18","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00404-011-2172-7","article-title":"Ovarian reserve and in\u00a0vitro fertilization cycles outcome according to women smoking status and stimulation regimen","volume":"285","author":"Freour","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"Engmann","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1472-6483(10)60127-7","article-title":"Poor ovarian response to gonadotrophin stimulation is associated with FSH receptor polymorphism","volume":"18","author":"Achrekar","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib24","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/humrep\/dem285","article-title":"The ISMAAR proposal on terminology for ovarian stimulation for IVF","volume":"22","author":"Nargund","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fendo.2019.00917","article-title":"Validation of ART calculator for predicting the number of metaphase II oocytes required for obtaining at least one euploid blastocyst for transfer in couples undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"10","author":"Esteves","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.fertnstert.2014.10.052","article-title":"Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antim\u00fcllerian hormone measurement","volume":"103","author":"Craciunas","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib27","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/humrep\/deab056","article-title":"Antral follicle count and anti-M\u00fcllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients","volume":"36","author":"Esteves","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clinbiochem.2021.05.007","article-title":"Association of ovarian response with picoAMH in women undergoing controlled ovarian hyperstimulation","volume":"95","author":"Bruno-Gaston","year":"2021","journal-title":"Clin Biochem"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/09513590.2020.1786509","article-title":"Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis","volume":"37","author":"Peluso","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/jhrs.JHRS_15_16","article-title":"Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in ART","volume":"10","author":"Vembu","year":"2017","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib32","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in\u00a0vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jfma.2017.05.009","article-title":"Feasibility of corifollitropin alfa\/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients","volume":"117","author":"Hwang","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1216584","article-title":"The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger","volume":"14","author":"Lee","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0015-0282(03)00566-1","article-title":"Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration","volume":"80","author":"Steinkampf","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib36","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10815-020-01865-9","article-title":"The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone","volume":"37","author":"Lee","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/09513590.2017.1291614","article-title":"Inter-cycle and inter-observer variability of the antral follicle count in routine clinical practice","volume":"33","author":"Subir\u00e1","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/cclm-2014-0022","article-title":"First fully automated immunoassay for anti-M\u00fcllerian hormone","volume":"52","author":"Gassner","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.fertnstert.2024.11.021_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12902-024-01627-z","article-title":"Association between anti-mullerian hormone and metabolic syndrome: insights from a prospective community-based study","volume":"24","author":"Amiri","year":"2024","journal-title":"BMC Endocr Disord"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224024014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224024014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:33:58Z","timestamp":1769747638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224024014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0015028224024014"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.021","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone and antral follicle count thresholds for hyperresponse risk assessment in in\u00a0vitro fertilization: a Hyperresponse Risk Assessment consensus study","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}